{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:23:57Z","timestamp":1648668237228},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ijcard.2014.03.047","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T19:15:57Z","timestamp":1395256557000},"page":"336","source":"Crossref","is-referenced-by-count":0,"title":["Insufficient use of mineralocorticoid receptor antagonists \u0131n patients that underwent renal sympathetic denervation for resistant hypertension"],"prefix":"10.1016","volume":"173","author":[{"given":"Ahmet","family":"Bacaksiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Uyarel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2014.03.047_bb0005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"Task Force Members. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"issue":"28","key":"10.1016\/j.ijcard.2014.03.047_bb0010","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/eurheartj\/eht154","article-title":"Expert consensus document from the European Society of Cardiology on catheter-based renal denervation","volume":"34","author":"Mahfoud","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ijcard.2014.03.047_bb0015","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ijcard.2012.07.027","article-title":"Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension","volume":"167","author":"Ukena","year":"2013","journal-title":"Int J Cardiol"},{"issue":"25","key":"10.1016\/j.ijcard.2014.03.047_bb0020","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity HTN-2 randomized, controlled trial","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2014.03.047_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ccd.24557","article-title":"Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study","volume":"81","author":"Kaltenbach","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ijcard.2014.03.047_bb0030","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24months","volume":"57","author":"Symplicity HTN-1 Investigators","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2014.03.047_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fphys.2012.00134","article-title":"Effects of renal sympathetic denervation on 24-hour blood pressure variability","volume":"3","author":"Zuern","year":"2012","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.ijcard.2014.03.047_bb0040","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"V\u00e1clav\u00edk","year":"2011","journal-title":"Hypertension"},{"issue":"6\u20137","key":"10.1016\/j.ijcard.2014.03.047_bb0045","first-page":"386","article-title":"Expert consensus: renal denervation for the treatment of arterial hypertension","volume":"105","author":"Pathak","year":"2012","journal-title":"Arch Cardiovasc Dis"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314004720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314004720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T23:59:02Z","timestamp":1538783942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314004720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0167527314004720"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.047","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}